|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Steliga MA and Dresler CM: Epidemiology of
lung cancer: smoking, secondhand smoke, and genetics. Surg Oncol
Clin N Am. 20:605–618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fucic A, Gamulin M, Ferencic Z, et al:
Lung cancer and environmental chemical exposure: a review of our
current state of knowledge with reference to the role of hormones
and hormone receptors as an increased risk factor for developing
lung cancer in man. Toxicol Pathol. 38:849–855. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yokota J, Shiraishi K and Kohno T: Genetic
basis for susceptibility to lung cancer: Recent progress and future
directions. Adv Cancer Res. 109:51–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jin S and Levine AJ: The p53 functional
circuit. J Cell Sci. 114:4139–4140. 2001.PubMed/NCBI
|
|
6
|
Momand J, Zambetti GP, Olson DC, George D
and Levine AJ: The mdm-2 oncogene product forms a complex with the
p53 protein and inhibits p53-mediated transactivation. Cell.
69:1237–1245. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thut CJ, Goodrich JA and Tjian R:
Repression of p53-mediated transcription by MDM2: a dual mechanism.
Genes Dev. 11:1974–1986. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bond GL, Hu W, Bond EE, et al: A single
nucleotide polymorphism in the MDM2 promoter attenuates the p53
tumor suppressor pathway and accelerates tumor formation in humans.
Cell. 119:591–602. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bond GL, Hu W and Levine A: A single
nucleotide polymorphism in the MDM2 gene: from a molecular and
cellular explanation to clinical effect. Cancer Res. 65:5481–5484.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wo X, Han D, Sun H, et al: MDM2 SNP309
contributes to tumor susceptibility: a meta-analysis. J Genet
Genomics. 38:341–350. 2011.PubMed/NCBI
|
|
11
|
Lind H, Zienolddiny S, Ekstrøm PO, Skaug V
and Haugen A: Association of a functional polymorphism in the
promoter of the MDM2 gene with risk of nonsmall cell lung cancer.
Int J Cancer. 119:718–721. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li G, Zhai X, Zhang Z, Chamberlain RM,
Spitz MR and Wei Q: MDM2 gene promoter polymorphisms and risk of
lung cancer: a case-control analysis. Carcinogenesis. 27:2028–2033.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pine SR, Mechanic LE, Bowman ED, et al:
MDM2 SNP309 and SNP354 are not associated with lung cancer risk.
Cancer Epidemiol Biomarkers Prev. 15:1559–1561. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu Z, Ma H, Lu D, et al: Genetic variants
in the MDM2 promoter and lung cancer risk in a Chinese population.
Int J Cancer. 118:1275–1278. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang X, Miao X, Guo Y, et al: Genetic
polymorphisms in cell cycle regulatory genes MDM2 and TP53 are
associated with susceptibility to lung cancer. Hum Mutat.
27:110–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park SH, Choi JE, Kim EJ, et al: MDM2
309T>G polymorphism and risk of lung cancer in a Korean
population. Lung Cancer. 54:19–24. 2006.
|
|
17
|
Liu G, Wheatley-Price P, Zhou W, et al:
Genetic polymorphisms of MDM2, cumulative cigarette smoking and
nonsmall cell lung cancer risk. Int J Cancer. 122:915–918. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mittelstrass K, Sauter W, Rosenberger A,
et al: Early onset lung cancer, cigarette smoking and the SNP309 of
the murine double minute-2 (MDM2) gene. BMC Cancer. 8:1132008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chua HW, Ng D, Choo S, et al: Effect of
MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and
survival among non-smoking Chinese women in Singapore. BMC Cancer.
10:882010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kohno T, Kunitoh H, Mimaki S, et al:
Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the
risk for lung squamous cell carcinoma. J Thorac Oncol. 6:813–817.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren YW, Yin ZH, Wan Y, et al: P53 Arg72Pro
and MDM2 SNP309 polymorphisms cooperate to increase lung
adenocarcinoma risk in Chinese female non-smokers: a case control
study. Asian Pac J Cancer Prev. 14:5415–5420. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Heist RS, Zhou W, Chirieac LR, et al: MDM2
polymorphism, survival, and histology in early-stage non-small-cell
lung cancer. J Clin Oncol. 25:2243–2247. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han JY, Lee GK, Jang DH, Lee SY and Lee
JS: Association of p53 codon 72 polymorphism and MDM2 SNP309 with
clinical outcome of advanced nonsmall cell lung cancer. Cancer.
113:799–807. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong J, Ren B, Hu Z, et al: MDM2 SNP309
contributes to non-small cell lung cancer survival in Chinese. Mol
Carcinog. 50:433–438. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhuo W, Zhang L, Zhu B, Ling J and Chen Z:
Association of MDM2 SNP309 variation with lung cancer risk:
evidence from 7196 cases and 8456 controls. PLoS One. 7:e415462012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Landi MT, Chatterjee N, Yu K, et al: A
genome-wide association study of lung cancer identifies a region of
chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum
Genet. 85:679–691. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hung RJ, McKay JD, Gaborieau V, et al: A
susceptibility locus for lung cancer maps to nicotinic
acetylcholine receptor subunit genes on 15q25. Nature. 452:633–637.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Broderick P, Webb E, et al: Common
5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet.
40:1407–1409. 2008. View
Article : Google Scholar
|
|
29
|
Shi J, Chatterjee N, Rotunno M, et al:
Inherited variation at chromosome 12p13.33, including RAD52,
influences the risk of squamous cell lung carcinoma. Cancer Discov.
2:131–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hosgood HD III, Wang WC, Hong YC, et al:
Genetic variant in TP63 on locus 3q28 is associated with risk of
lung adenocarcinoma among never-smoking females in Asia. Hum Genet.
131:1197–1203. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ahn MJ, Won HH, Lee J, et al: The 18p11.22
locus is associated with never smoker non-small cell lung cancer
susceptibility in Korean populations. Hum Genet. 131:365–372. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu Z, Wu C, Shi Y, et al: A genome-wide
association study identifies two new lung cancer susceptibility
loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet. 43:792–796.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shiraishi K, Kunitoh H, Daigo Y, et al: A
genome-wide association study identifies two new susceptibility
loci for lung adenocarcinoma in the Japanese population. Nat Genet.
44:900–903. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lan Q, Hsiung CA, Matsuo K, et al:
Genome-wide association analysis identifies new lung cancer
susceptibility loci in never-smoking women in Asia. Nat Genet.
44:1330–1335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mitani Y, Lezhava A, Kawai Y, et al: Rapid
SNP diagnostics using asymmetric isothermal amplification and a new
mismatch-suppression technology. Nat Methods. 4:257–262. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Enokida Y, Shimizu K, Atsumi J, et al:
Rapid detection of SNP (c.309T>G) in the MDM2 gene by the Duplex
SmartAmp method. PLoS One. 8:e601512013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Miyamae Y, Shimizu K, Mitani Y, et al:
Mutation detection of epidermal growth factor receptor and KRAS
genes using the smart amplification process version 2 from
formalin-fixed, paraffin-embedded lung cancer tissue. J Mol Diagn.
12:257–264. 2010. View Article : Google Scholar
|
|
38
|
Ryan BM, Calhoun KM, Pine SR, et al: MDM2
SNP285 does not antagonize the effect of SNP309 in lung cancer. Int
J Cancer. 131:2710–2716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He W, Long J, Xian L, et al: MDM2 SNP309
polymorphism is associated with lung cancer risk in women: A
meta-analysis using METAGEN. Exp Ther Med. 4:569–576.
2012.PubMed/NCBI
|
|
40
|
Bond GL, Hirshfield KM, Kirchhoff T, et
al: MDM2 SNP309 accelerates tumor formation in a gender-specific
and hormone-dependent manner. Cancer Res. 66:5104–5110. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu JN, Zhang XM, Guo YL, Sun T, Lin DX
and Wen T: Genetic polymorphism in MDM2 is associated with
susceptibility to colorectal cancer in a Chinese population.
Zhonghua Zhong Liu Za Zhi. 30:335–338. 2008.(In Chinese).
|
|
42
|
Alberg AJ, Ford JG and Samet JM; American
College of Chest Physicians. Epidemiology of lung cancer: ACCP
evidence-based clinical practice guidelines (2nd edition). Chest.
132(Suppl 3): 29S–55S. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Knappskog S, Bjørnslett M, Myklebust LM,
et al: The MDM2 promoter SNP285C/309G haplotype diminishes Sp1
transcription factor binding and reduces risk for breast and
ovarian cancer in Caucasians. Cancer Cell. 19:273–282. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nana-Sinkam SP and Powell CA: Molecular
biology of lung cancer: diagnosis and management of lung cancer,
3rd ed: American College of Chest Physicians evidence-based
clinical practice guidelines. Chest. 143(5 Suppl): e30S–e39S. 2013.
View Article : Google Scholar
|
|
45
|
Mitsudomi T and Yatabe Y: Mutations of the
epidermal growth factor receptor gene and related genes as
determinants of epidermal growth factor receptor tyrosine kinase
inhibitors sensitivity in lung cancer. Cancer Sci. 98:1817–1824.
2007. View Article : Google Scholar : PubMed/NCBI
|
